This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Janssen Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Journey of Michal Sarnecki
Introduction
Michal Sarnecki, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of immunology. His work focuses on developing innovative vaccine compositions aimed at protecting against extra-intestinal pathogenic E. coli (ExPEC). With one patent to his name, Sarnecki’s achievements highlight the importance of research and innovation in addressing public health challenges.
Latest Patents
Michal Sarnecki holds a patent for "Multivalent vaccine compositions and uses thereof." This innovative patent details compositions and methods designed to induce an immune response against ExPEC, thereby offering immune protection against diseases associated with these pathogenic strains. Specifically, the patent describes the use of conjugates of polysaccharide antigen O75 covalently bound to a carrier protein to prevent invasive ExPEC disease. This groundbreaking work stands at the forefront of vaccine development related to ExPEC infections.
Career Highlights
Sarnecki is currently employed at Janssen Pharmaceuticals, Inc., a company renowned for its commitment to advancing health through innovative pharmaceuticals. His role involves collaborating with multidisciplinary teams to drive forward research aimed at creating effective health interventions. His notable patent demonstrates his ability to bridge scientific inquiry with practical medical applications, reflecting his expertise in the field.
Collaborations
Throughout his career, Michal Sarnecki has collaborated with esteemed colleagues, including Jan Theunis Poolman and Kellen Cristhina Fae. These partnerships highlight the collaborative nature of scientific research, as they work together to advance knowledge and develop solutions for pressing health issues. The synergy between Sarnecki and his coworkers reinforces the importance of teamwork in innovation.
Conclusion
In summary, Michal Sarnecki's contributions to vaccine development are noteworthy and impactful. His patent for multivalent vaccine compositions is a significant step towards enhancing immune protection against ExPEC diseases. As he continues his work at Janssen Pharmaceuticals, Inc., Sarnecki exemplifies the role of inventors in shaping the future of healthcare through innovation and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile